Multicenter survey on mesalamine intolerance in patients with ulcerative colitis

Background and Aim Although oral mesalamine is the first‐choice drug for treating mild‐to‐moderate ulcerative colitis (UC), some patients show symptoms of intolerance, including exacerbation of diarrhea and abdominal pain. The present study clarified the current state and clinical courses of patient...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of gastroenterology and hepatology 2021-01, Vol.36 (1), p.137-143
Hauptverfasser:	Hiraoka, Sakiko, Fujiwara, Akiko, Toyokawa, Tatsuya, Higashi, Reiji, Moritou, Yuki, Takagi, Shinjiro, Matsueda, Kazuhiro, Suzuki, Seiyuu, Miyaike, Jiro, Inokuchi, Toshihiro, Takahara, Masahiro, Kato, Jun, Okada, Hiroyuki
Format:	Artikel
Sprache:	eng
Schlagworte:	clinical intestinal disorders Colorectal surgery Diarrhea epidemiology Fever frequency Inflammatory bowel disease Intolerance mesalamine intolerance Pain Patients prognosis readministration Remission Risk factors Sulfasalazine Ulcerative colitis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!